title: Corticosteroid-sparing effect of etanercept in idiopathic panuveitis resistant to immunosuppressive therapy.
abstract: Uveitis, an inflammatory eye disease with varying immunopathogenic mechanisms, may be associated with autoimmune disorders, may be secondary to infection, or may be idiopathic. Response to treatment of uveitis is inconsistent. In this report we describe an adult with idiopathic panuveitis who attempted to lower his oral corticosteroid dose from intolerable levels but was unable to do so because of the reappearance of symptoms. His 8-year course was managed with ocular and systemic corticosteroids, methotrexate, and cyclosporine, which allowed only partially successful control of his ocular inflammation. Complete control was not achieved until the addition of etanercept. With this case report we are the first to describe the complete response of idiopathic panuveitis to etanercept. Our success with this patient strongly supports the critical role of tumor necrosis factor in the immunopathogenesis of some cases of idiopathic panuveitis. Furthermore, etanercept offers a relatively nontoxic, safe option in cases of panuveitis that are unresponsive to traditional immunosuppressive therapy.
authors.affiliation: McIntosh Clinic, P.C., Section: Rheumatology, Thomasville, Georgia 31792, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Smith
authors.forename: V M
authors.initials: VM
authors.lastname: McMillan
authors.forename: J S
authors.initials: JS
authors.lastname: Newton